REVIEW ON HETEROCYCLIC COMPOUNDS SYNTHESIS AND EVALUATION
HTML Full TextREVIEW ON HETEROCYCLIC COMPOUNDS SYNTHESIS AND EVALUATION
Komal Sachdeva, Neelam Sihag, Dinesh Kumar, Rajni Tanwar, Sunita Devi and Puja Gulati *
Department of Pharmaceutical Sciences, Desh Bhagat University, Mandi Govindhgarh, Punjab, India.
ABSTRACT: Among all the organic compounds, heterocyclic compounds are the most common and varied class. It has been possible to synthesis a considerable number of heterocyclic molecules thus far. Heterocyclic compounds are getting more and more prevalent due to extensive synthetic study and their synthetic utility. In the realm of medical chemistry, these molecules are useful in several ways. Some common uses include dyes, disinfectants, corrosion inhibitors, antioxidants, and copolymer production. An effective strategy for synthesizing recently identified heterocyclic compounds and their moieties always has some distinctive features. The importance of heterocyclic compounds in curative chemistry has been shown through their neoteric advancements. These compounds exhibit biological activities such as anti-convulsant, anti-HIV, antiviral, anti-allergic, anti-cancer, anti-inflammatory, and antifungal properties. This article gives comprehensive information about these heterocyclic compounds.
Keywords: Indole, Pyrazole, Antimicrobial activity, Anti-inflammatory activity
INTRODUCTION: The field of medicinal chemistry is very vast and includes the aspects of various types of chemistry, biology and computations 1. The increase in drug resistance towards antimicrobial therapeutics has pressurized medicinal chemist to unearth novel drug candidates for the treatment of resistant diseases 2. Inflammation is a physiological reaction which cause reddened, swollen, hot, and often painful, especially as a reaction to injury or infection on body parts and it is associate with many chronic diseases, including allergy, arthritis and auto-immune disease 3. Heterocyclic chemistry deals with heterocyclic compounds which constitute about sixty-five percent of organic chemistry literature. A large number of heterocyclic compounds, both synthetic and natural, are pharmacologically active and are in clinical use 4.
Heterocyclic Compounds: Heterocycles are an extraordinarily important and unique class of compounds; they make up more than half of all known organic compounds and have a wide range of physical, chemical and biological properties spanning a broad spectrum of reactivity and stability 5. Heterocyclic chemistry is the branch of organic chemistry dealing with the synthesis, properties, and applications of these heterocycles 6.
FIG. 1: STRUCTURE OF VARIOUS HETEROCYCLIC COMPOUNDS
Pyrazole: The term pyrazole was given to this class of compounds by German chemist Ludwig Knorr in 1883. In a classic method developed by German chemist Hans von Pechmann in 1898, pyrazole was synthesized from acetylene and diazomethane 7. Pyrazoles are five member ring heterocyclic compounds, have some structural features with two nitrogen atoms in adjacent position and are also called as azoles 8. Pyrazoles are aromatic molecules by to their planar conjugated ring structures with six delocalized π-electrons. Therefore, many important properties of these molecules were analyzed by comparing with the properties of benzene derivatives 9.
FIG. 2: STRUCTURE OF PYRAZOLE
Some Synthetic Methods of Pyrazole:
Knorr Pyrazole Synthesis: The Knorr pyrazole synthesis is an organic reaction used to convert a hydrazine or its derivatives and a 1,3-dicarbonyl compound to a pyrazole using an acid catalyst. The mechanism begins with an acid catalyzed imine formation, where in the case of hydrazine derivatives the attack can happen on either carbonyl carbon and result in two possible products. The other nitrogen of the hydrazine derivative then attacks the other carbonyl group which has also been protonated by the acid and forms a second imine group. This diimine compound gets deprotonated to regenerate the acid catalyst and provide the final pyrazole product.
3,5-disubstituted 1H-pyrazoles can be prepared by condensation of substituted aromatic aldehydes and to sylhydrazine followed by cycloaddition reaction with terminal alkynes. The reaction is one pot, highly efficient, general and bears a variety of functional groups and sterically hindered substrates to make the pyrazole 67.
A very efficient [3,3] sigmatropic rearrangement of N-propargylhydrazones affords convenient access to different functionalized pyrazoles 68.
4-substituted 1H-pyrazole-5-carboxylates can be made by the cyclocondensation of unsymmetrical enaminodiketones with tert-butylhydrazine hydrochloride or carboxy-methylhydrazine. The regiospecific pyrazoles are formed in good yields 69.
FIG. 3: KNORR PYRAZOLE SYNTHESIS
Indole: Development of indole chemistry started with the study of the indigo dye. Indigo may be transformed to isatin and after that to oxindole. In 1866, Adolf von Baeyer prepared indole by reducing oxindole to indole using zinc dust 14.
Certain indole derivatives were significant dyestuffs until the end of the 19th century. In the 1930s, concern in indole intensified when it became known that the indole substituent is present in many essential alkaoloids (e.g., tryptophan and auxins), and it remains an active area of research today 15.
Indole is an aromatic heterocyclic organic compound with the formula. It has a bicyclic structure, consisting of a six-membered benzene ring fused to a five-membered pyrrole ring. Indole is brodly distributed in the nature and can be produced by a range of bacteria. As an intercellular signal molecule, indole regulates various aspects of bacterial physiology, as well as spore formation, plasmid stability, resistance to drugs, biofilm formation, and virulence 16. The amino acid tryptophan is an indole derivative and the precursor of the neurotransmitter serotonin 17.
FIG. 4: STRUCTURE OF INDOLE
Some Synthetic Method of Indole:
Leimgruber –Batcho Indole Synthesis: The Leimgruber-Batcho indole synthesis is a series of organic reaction that produce indoles from o-nitrotoluenes 18. The first step is the formation of an enamine 2 using N,N-dimethylformamide dimethyl acetal and pyrrolidine 19. The desired indole 3 is then formed in a second step by reductive cyclisation.
FIG. 5: LEIMGRUBER-BATCHO INDOLE SYNTHESIS
In the above scheme, the reductive cyclisation is effected by Raney nickel and hydrazine. Palladium on carbon and hydrogen, stannous chloride, sodium hydrpsulfite 20 or ironin acetic acid 21 are also effective reducing agents.
Fischer Indole Synthesis: The Fischer indole synthesis is a chemical reaction that generate the aromatic heterocycle indole from a (substituted) phentlhydrazine and an aldehyde or ketone under acidic condition 22.
The reaction was discovered in 1883 by Hermann Emil Fischer. Antimigraine drugs of the triptan class are often synthesized by this method.
FIG. 6: FISCHER INDOLE SYNTHESIS
The choice of acid catalyst is very important. Brønsted acids such as HCl, H2SO4, polyphosphoric acid and p-toluenesulfonic acid have been used successfully. Lewis acidssuch as boron trifluoride, zinc chloride, iron chloride, and aluminium chloride are also useful catalysts for this reaction
The available literature reports on pyrazole, indole and its derivatives were collected and they are compiled in the following table to get an over view of the knowledge already available on these derivatives and to plan for new pyrazole and indole derivatives.
Literature Review: The Pyrazole and indole moieties were searched in various journals and website extensively. Some interesting reports on derivatives of these nuclei are shown below
Pyrazole:
Antimicrobial Activity:
TABLE 1: LITERATURE REPORTS ON PYRAZOLE AND INDOLE DERIVATIVES AND THEIR BIOLOGICAL POTENTIAL
Sr. no. | Author | Year | Active molecules |
1 | Amir et. al.(23) | 2011 | 1-(6’-Chlorobenzothiazol-2-yl)-3-methyl-4(4”bromophenylhydrazono)-2-pyrazolin-5-one. |
2 | Khloya et. al.(24) | 2013 | be 4-[4-[(3-methyl-5-oxo-1-phenyl-1,5-dihydro-4H-pyrazol-4-ylidene)methyl]-3-phenyl-1H-pyrazol-1-yl]benzenesulfonamide |
3 | Basha et. al.(25) | 2015 | (4-(2,4-dichlorothiazol-5-yl)-1Hpyrazol-3-yl)(4-nitrophenyl) methanone. |
4 | Rahimizadeh et.al.(26) | 2010 | N1-[4-cyano-1-(2,4-dinitrophenyl)-1H-5-pyrazolyl]-4cyanobenzamide |
5 | Laxmi et.al.(27) | 2013 | 5-((3-(6-Bromo-2-oxo-2H-chromene-3-yl)-1 phenyl 1H pyrazol4yl) methylene) pyrimidine2,4,6(1H,3H,5H)-trione. |
6 | Isloor et.al.(28) | 2012 | N-cyclohexyl-5-phenyl-1-(quinolin-2-yl)-1H-pyrazole-4-carboxamide. |
Anti-inflammatory activity | |||
Sr. no. | Author | Year | Active molecules |
1 | Kumar et.al.(29) | 2012 | 4-(4-{[2-(4-(4-Chlorophenyl)-1,3-thiazol-2yl)hydrazono]methyl}-3-phenyl-1H-pyrazol-1yl)benzenesulfonamide. |
2 | Mashooq A. et.al.(30) | 2017 | 7-Methyl-2-(4-sulfonamidophenyl)-4-(3,4,5 trimethoxyphenyl)-2H-pyrazolo[3,4-d] pyridazin. |
3 | Kumar et.al.(31) | 2016 | 2-((3-hydroxy-5-methyl-4H-pyrazol-4-yl)(4-hydroxyphenyl)methyl)hydrazinecarboxamide. |
4 | Chandna et.al.(32) | 2014 | 1-{4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzyl}-1H-1,2,4-triazole. |
5 | Khaled R.et.al.(33) | 2015 | 5-Furan-2-yl-1-(4-methanesulfonylphenyl)-3-trifluoromethyl1H-pyrazole. |
Analgesic Activity | |||
Sr. no. | Author | Year | Active molecules |
1 | Domiati.et.al.(34) | 2016 | (E)-N'-(4-(4-(1-acetyl-3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-3-p-tolyl-1H-pyrazol-1-yl)phenylthioperoxy)-N,N-dimethylformamidine. |
2 | Karrouchi et.al.(35) | 2016 | be 5-(5(3)-methyl-1H-pyrazol-3(5)-yl)-4-((4-nitrobenzylidene)amino)-4H-1,2,4-triazole-3-thiol. |
3 | Kumar et.al.(36) | 2013 | 5-(4,6-Dimethoxybenzofuran-5-yl)-1H-pyrazole. |
4 | Jayanna et.al.(37) | 2013 | 1-(5,7-Dichloro-1,3-benzoxazol-2-yl)-3-(4-bromophenyl)-1H-pyrazole-4-carbaldehyde. |
5 | Chikkula.et.al.(38) | 2017 | 4-(2-(4-(1H-Benzimidazol-2-yl)phenyl)hydrazono)-1-(4- chlorophenyl)-3-methyl-1H-pyrazol-5(4H)-one. |
Antiviral activity | |||
Sr. no. | Author | Year | Active molecules |
1 | Sabbagh.et.al.(39) | 2009 | 1-Acetyl-5-(4-(benzyloxy)phenyl)-3-(4-chlorophenyl)-4,5- dihydro-(1H)-pyrazole |
2 | Tantawy et.al.(40) | 2012 | be6-(4-bromophenyl)-4-(3-methyl-1,5-diphenyl-1H-pyrazol4-yl)-2-oxo-1,2-dihydropyridine-3-carbonitrile. |
3 | Gomha et.al.(41) | 2014 | (E)-1-(4-bromophenyl)-2-(2-(4-(4-chlorophenyl)-3-phenyl-4H-pyrazolo[4,3-d]isoxazol-5(6H)-yl)-4-methylthiazol-5-yl)diazene. |
Anticancer activity | |||
Sr. no. | Author | Year | Active molecule |
1 | Shi et.al.(42) | 2015 | (E)-4-(3-(Furan-2-yl) acrylamido)-1-methyl-3-propyl 1H-pyrazole-5-carboxamide. |
2 | Siddiqui et.al.(43) | 2015 | 3 -[3',5'-Dimethyl pyrazole-1-yl]carbonylmethoxycholest-5-ene. |
3 | Bai et.al.(44) | 2012 | N-(1,5-diacetyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)benzamide. |
4 | Rai U.et.al.(45) | 2014 | (E)-3-(3-(4-fluorophenyl)-1H-pyrazol-4-yl)-1-(5-fluoropyridin-2-yl)prop-2-en-1-one. |
5 | Sham et.al.(46) | 2012 | N,N-dimethyl-4[1-phenyl-3-(pyridin-2-yl)-4,5-dihydro-1H pyrazol-5-yl] benzenamine. |
Indole:
Antimicrobial Activity:
CONCULSION: One of the most important classes of organic molecules in medical chemistry are heterocyclic compounds, which are utilized as drugs to treat a variety of illnesses. Heterocyclic compounds have been demonstrated to have a broad range of medicinal pharmacological uses through a number of remarkable achievements. Because of their fascinating biological activity, heterocyclic molecules are useful synthetic targets and important structural elements in organic synthesis and medicinal chemistry. The pharmaceutical world is very interested in the prospective uses of heterocycles as antiviral, anticancer, anti-inflammatory, antifungal, antibacterial, anti-Alzheimer's, and antidiabetic medicines, among other uses. It's interesting to note that in continuing drug development, a growing number of heterocycles have been identified as possible therapeutic candidates.
Consent for Publication: Not applicable.
Availability of Data and Materials: All the data is available in the manuscript.
Funding: None.
Ethical Approval: Not applicable
ACKNOWLEDGEMENT: None.
CONFLICT OF INTEREST: The authors declare that there is no conflict of interest.
REFERENCES:
- Madesn U, Krogsgaaard-Larsen P and Lijefors T: “Textbook of Drug Design and Discovery. Washington, DC: Taylor & Francis 2002.
- Hughes J, Rees S and Kalindjian S: “Principles of early drug discovery”, British Journal of Pharmacology 2011; 162 (6): 1239-1249.
- Iyer VB, Gurupadayya B, Koganti VS, Inturi B and Chandan RS: Design, synthesis and biological evaluation of 1,3,4-oxadiazole as promising anti-inflammatory agents. Medicinal Chemistry Research 2017; 26(1): 190-204.
- Arora P, Arora V, Lamba HS and Wadhwa D: Importance of heterocyclic chemistry: A review. International Journal of Pharmaceutical Sciences and Research 2012; 3(9): 2947.
- Eftekhari-Sis B, Zirak M and Akbari A: Chem Rev 2013; 113: 2958–3043.
- Thomas L: Gilchrist "Heterocyclic Chemistry" 3rd ed. Addison Wesley: Essex, England 1997; 414.
- Von Pechmann and Hans: "Pyrazol was Acetylen and Diazomethan". Berichte der deutschen chemischen Gesellschaft (in German) 1898; 31(3): 2950–2951.
- Eicher T and Hauptmann S: Edition ‘The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and applications’, Wiley 2003.
- Krygowski TM, Anulewicz R, Cyrafiski MK, Puchala A and Rasata D: Tetrahedron 1998; 54: 12295.
- Knorr and Ludwig: "Synthese von Pyrrolderivaten" [Synthesis of pyrrole derivatives]. Berichte der deutschen chemischen Gesellschaft (in German) 1884; 17(2): 1635–164
- Corwin, Alsoph Henry: "The Chemistry of Pyrrole and its Derivatives". In Elderfield, Robert Cooley. Heterocyclic Compounds. 1. New York: Wiley 1950; 287.
- Paal C: "Ueber die Derivate des Acetophenonacetessigesters und des Acetony-lacetessigesters", Berichte der deutschen chemischen Gesellschaft 1884; 17: 2756.
- Amarnath V and Amarnath K: "Intermediates in the Paal-Knorr Synthesis of Furans", The Journal of Organic Chemistry 1995; 60: 301.
- Baeyer A: "Ueber die Reduction aromatischer Verbindungen mittelst Zinkstaub"[On the reduction of aromatic compounds by means of zinc dust]. Annalen der Chemie and Pharmacie 1866; 140(3): 295–296.
- Van Order RB and Lindwall HG: "Indole". Chem Rev 1942; 30: 69–96.
- Lee, Jin-Hyung, Lee and Jintae: "Indole as an intercellular signal in microbial communities". FEMS Microbiology Reviews 2010; 34(4): 426.
- Nelson, David L, Cox and Michael M: Principles of Biochemistry (4th ed.), New York: W. H. Freeman 2005.
- Batcho AD and Leimgruber W: Org Synth 1985; 63: 214–220.
- Maehr H and Smallheer JMJ: Org Chem 1981; 46: 1753.
- Garcia EE and Fryer RIJ: Heterocycl Chem 1974; 11: 219.
- Ponticello GS and Baldwin JJJ: Org Chem 1979; 44: 4003.
- Fischer E and Jourdan F: "Ueber die Hydrazine der Brenztraubensäure". Berichte der Deutschen Chemischen Gesellschaft 1883; 1 (2): 2241–2245.
- Amir, Mohd, Sadique A. Javed and Mohd Zaheen Hassan: "Synthesis and antimicrobial activity of pyrazolinones and pyrazoles having benzothiazole moiety." Medicinal Chemistry Research 2012; 21(7): 1261-1270.
- Khloya P, Kumar P, Mittal A, Aggarwal NK and Sharma PK: Synthesis of some novel 4-arylidene pyrazoles as potential antimicrobial agents. Organic and Medicinal Chemistry Letters 2013; 3(1): 9.
- Basha and Shaik Sharafuddin: "Synthesis and antimicrobial activity of 3-aroyl-4-heteroaryl pyrroles and pyrazoles." Medicinal Chemistry Research 2015; 24(3): 954-964.
- Rahimizadeh M, Pordel M, Bakavoli M, Rezaeian S & Sadeghian A: Synthesis and antibacterial activity of some new derivatives of pyrazole. World Journal of Microbiology and Biotechnology 2010; 26(2): 317-321.
- Laxmi S. Vijaya, B. Suresh Kuarm and Rajitha B: "Synthesis and antimicrobial activity of coumarin pyrazole pyrimidine 2, 4, 6 (1H, 3H, 5H) triones and thioxopyrimidine4, 6 (1H, 5H) diones." Medicinal Chemistry Research 2013; 22(2): 768-774.
- Chandrakantha B, Isloor AM, Peethamber SK & Shetty P: T3P mediated synthesis of some new quinoline substituted pyrazole derivatives and its antibacterial studies. Der Pharma Chemica 2012; 4(4): 1723-1729.
- Kumar P, Chandak N, Kaushik P, Sharma C, Kaushik D, Aneja KR & Sharma PK: Synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory–antibacterial agents. Medicinal Chemistry Research 2012; 21(11): 3396-3405.
- Bhat, Mashooq A, Atallah F. Ahmed, Zhi-Hong Wen, Mohamed A. Al-Omar and Hatem A. Abdel-Aziz: "Synthesis, anti-inflammatory and neuroprotective activity of pyrazole and pyrazolo [3, 4-d] pyridazine bearing 3, 4, 5-trimethoxyphenyl." Medicinal Chemistry Research 2017; 26(7): 1557-1566.
- Kumar, R. Surendra, Ibrahim A. Arif, Anis Ahamed and Akbar Idhayadhulla: "Anti-inflammatory and antimicrobial activities of novel pyrazole analogues." Saudi Journal of Biological Sciences 2016; 23(5): 614-620.
- Chandna N, Kapoor JK, Grover J, Bairwa K, Goyal V and Jachak SM: Pyrazolylbenzyltriazoles as cyclooxygenase inhibitors: synthesis and biological evaluation as dual anti-inflammatory and antimicrobial agents. New Journal of Chemistry 2014; 38(8): 3662-3672.
- Abdellatif, Khaled RA, Eman KA Abdelall, Wael AA Fadaly and Gehan M. Kamel: "Synthesis, cyclooxygenase inhibition, and anti-inflammatory evaluation of novel diarylheterocycles with a central pyrazole, pyrazoline, or pyridine ring." Medicinal Chemistry Research 2015; 24(6): 2632-2644.
- Domiati, Souraya, Ahmed El-Mallah, Asser Ghoneim, Adnan Bekhit and Heba Abd El Razik: "Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives." Inflammopharmacology 2016; 24(4): 163-172.
- Karrouchi K: "Synthesis, antioxidant and analgesic activities of Schiff bases of 4-amino-1, 2, 4-triazole derivatives containing a pyrazole moiety." Annales pharmaceutiques francaises. 2016; 74: 6. Elsevier Masson.
- Kumar, Harish, Deepika Saini, Sandeep Jain and Neelam Jain: "Pyrazole scaffold: a remarkable tool in the development of anticancer agents." European Journal of Medicinal Chemistry 2013; 70: 248-258.
- Jayanna ND, Vagdevi HM, Dharshan JC, Raghavendra R and Sandeep B. Telkar: "Synthesis, antimicrobial, analgesic activity, and molecular docking studies of novel 1-(5, 7-dichloro-1, 3-benzoxazol-2-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde derivatives." Medicinal Chemistry Research 2013; 22(12): 5814-5822.
- Chikkula KV and Sundararajan R: Analgesic, anti-inflammatory, and antimicrobial activities of novel isoxazole/pyrimidine/pyrazole substituted benzimidazole analogs. Medicinal Chemistry Research 2017; 26(11): 3026-37.
- El-Sabbagh, Osama I, Mohamed M. Baraka, Samy M. Ibrahim, Christophe Pannecouque, Graciela Andrei, Robert Snoeck, Jan Balzarini, and Adel A. Rashad: "Synthesis and antiviral activity of new pyrazole and thiazole derivatives." European Journal of Medicinal Chemistry 2009; 44(9): 3746-3753.
- Tantawy AS, Nasr MN, El-Sayed MA and Tawfik SS: Synthesis and antiviral activity of new 3-methyl-1, 5-diphenyl-1H-pyrazole derivatives. Medicinal Chemistry Research 2012; 21(12): 4139-4149.
- Gomha SM, Badrey MG, Abdalla MM & Arafa RK: Novel anti-HIV-1 NNRTIs based on a pyrazolo [4, 3-d] isoxazole backbone scaffold: design, synthesis and insights into the molecular basis of action. Med Chem Comm 2014; 5(11): 1685-1692.
- Shi and Jing Bo: "Novel pyrazole-5-carboxamide and pyrazole–pyrimidine derivatives: Synthesis and anticancer activity." European Journal of Medicinal Chemistry 2015; 90: 889-896.
- Siddiqui T, Alam MG & Dar AM: Synthesis, characterization and anticancer studies of new steroidal oxadiazole, pyrrole and pyrazole derivatives. Journal of Saudi Chemical Society 2015; 19(4): 387-391.
- Bai XG, Yu DK, Wang JX, Zhang H, He HW, Shao RG & Wang YC: Design, synthesis and anticancer activity of 1-acyl-3-amino-1, 4, 5, 6-tetrahydropyrrolo [3, 4-c] pyrazole derivatives. Bioorganic & Medicinal Chemistry Letters 2012; 22(22): 6947-6951.
- Rai U. Sankappa, Arun M. Isloor, Prakash Shetty, KSR. Pai and Hoong-Kun Fun: "Synthesis and in-vitro biological evaluation of new pyrazole chalcones and heterocyclic diamides as potential anticancer agents." Arabian Journal of Chemistry 2015; 8(3): 317-321.
- Sondhi, Sham M., Sandeep Kumar, Nikhil Kumar and Partha Roy: "Synthesis anti-inflammatory and anticancer activity evaluation of some pyrazole and oxadiazole derivatives." Medicinal Chemistry Research 2012; 21(10): 3043-3052.
- Tiwari RK, Singh D, Singh J, Yadav V, Pathak AK, Dabur R, Chhillar AK, Singh R, Sharma GL, Chandra R and Verma AK: Synthesis and antibacterial activity of substituted 1, 2, 3, 4-tetrahydropyrazino [1, 2-a] indoles. Bioorg & Medicinal Chemistry Letters 2006; 16(2): 413-6.
- Al-Qawasmeh, Raed A., Mario Huesca, Venkata Nedunuri, Robert Peralta, Jim Wright, Yoon Lee and Aiping Young: "Potent antimicrobial activity of 3-(4, 5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus." Bioorganic & Medicinal Chemistry Letters 2010; 20(12): 3518-3520.
- Choppara P, Bethu MS, Prasad YV, Rao JV, Ranjan TU, Prasad GS & Murthy YLN: Synthesis, characterization and cytotoxic investigations of novel bis (indole) analogues besides antimicrobial study. Arabian J of Chemistry 2015.
- Rajaraman D, Sundararajan G, Loganath NK and Krishnasamy K: "Synthesis, molecular structure, DFT studies and antimicrobial activities of some novel 3-(1-(3, 4-dimethoxyphenethyl)-4, 5-diphenyl-1H-imidazol-2-yl)-1H-indole derivatives and its molecular docking studies." Journal of Molecular Structure 2017; 1127: 597-610.
- Majik MS, Rodrigues C, Mascarenhas S and D’Souza L: Design and synthesis of marine natural product-based 1H-indole-2, 3-dione scaffold as a new antifouling/antibacterial agent against fouling bacteria. Bioorganic Chemistry 2014; 54: 89-95.
- Z huang SH, Lin YC, Chou LC, Hsu MH, Lin HY, Huang CH, Lien JC, Kuo SC and Huang LJ: Synthesis and anticancer activity of 2, 4-disubstituted furo [3, 2-b] indole derivatives. European Journal of Medicinal Chemistry. 2013; 1(66): 466-79.
- Gudipati, Rajyalakshmi, Rama Narsimha Reddy Anreddy, and Sarangapani Manda: "Synthesis, characterization and anticancer activity of certain 3-{4-(5-mercapto-1, 3, 4-oxadiazole-2-yl) phenylimino} indolin-2-one derivatives." Saudi Pharmaceutical Journal 2011; 19(3): 153-158.
- Budovská, Mariana, Martina Pilátová, Lenka Varinská, Ján Mojžiš and Roman Mezencev: "The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin." Bioorganic & Medicinal Chemistry 2013; 21(21): 6623-6633.
- Cihan-Üstündağ, Gökçe and Gültaze Çapan: "Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents." Molecular Diversity 2012; 16(3): 525-539.
- Zahran, Magdy AH and Atef M: Ibrahim. "Synthesis and cellular cytotoxicities of new N-substituted indole-3-carbaldehyde and their indolylchalcones." Journal of Chemical Sciences 2009; 121 (4): 455-462.
- Xue, Situ, Linlin Ma, Rongmei Gao, Yuhuan Li and Zhuorong Li: "Synthesis and antiviral activity of some novel indole-2-carboxylate derivatives." Acta Pharmaceutica Sinica B 2014; 4(4): 313-321.
- Sellitto, Grazia, Aurora Faruolo, Paolo de Caprariis, Sergio Altamura, Giacomo Paonessa and Gennaro Ciliberto: "Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in-vitro." Bioorganic & medicinal chemistry 2010; 18(16): 6143-6148.
- Terzioglu, Nalan, Nilgün Karali, A. Gursoy, Christophe Pannecouque, Pieter Leysen, Jan Paeshuyse, Johan Neyts, and Erik De Clercq: "Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives." Arkivoc 2006; 1: 109-118.
- Schuck, Desirée C, Alessandro K. Jordão, Myna Nakabashi, Anna C. Cunha, Vitor F. Ferreira and Célia RS Garcia: "Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum." European Journal of Medicinal Chemistry 2014; 78: 375-382.
- Bharate, Sandip B, Rammohan R. Yadav, Shabana I. Khan, Babu L. Tekwani, Melissa R. Jacob, Ikhlas A. Khan and Ram A: Vishwakarma. "Meridianin G and its analogs as antimalarial agents." Med Chem Comm 2013; 4(6): 1042-1048.
- Shingade, Sunil G, Sanjaykumar B. Bari, Pooja Agarwal and Kumkum Srivastava: "Novel 5-chloroindoline-2, 3-dione derivatives: Synthesis, characterization and preliminary evaluation for antimalarial activity." 2013.
How to cite this article:
Sachdeva K, Kumar D, Gulati P, Tanwar R, Sihag N and Devi S: Review on heterocyclic compounds synthesis and evaluation. Int J Pharm Sci & Res 2024; 15(12): 3416-29. doi: 10.13040/IJPSR.0975-8232.15(12).3416-29
All © 2024 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
4
3416-3429
3954 KB
49
English
IJPSR
Komal Sachdeva, Neelam Sihag, Dinesh Kumar, Rajni Tanwar, Sunita Devi and Puja Gulati *
Department of Pharmaceutical Sciences, Desh Bhagat University, Mandi Govindhgarh, Punjab, India.
puja_duggal@yahoo.co.in
29 May 2024
03 July 2024
25 October 2024
10.13040/IJPSR.0975-8232.15(12).3416-29
01 December 2024